Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 934-945

  Finegold, Judith A ^a   Asaria, Perviz ^b   Francis, Darrel P ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Coronary heart disease; Ischaemic heart disease; Mortality; Trends

Indexed keywords

AGE DISTRIBUTION; ARTICLE; ASIA; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; DEVELOPED COUNTRY; DEVELOPING COUNTRY; EASTERN EUROPE; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HUMAN; ISCHEMIC HEART DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; REGIONALIZATION; STANDARDIZED MORTALITY RATIO; STATISTICAL ANALYSIS; TREND STUDY; UNITED NATIONS; WORLD HEALTH ORGANIZATION;

CORONARY HEART DISEASE; ISCHAEMIC HEART DISEASE; MORTALITY; TRENDS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ASIA; CAUSE OF DEATH; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; UNITED NATIONS; UNITED STATES; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84885290802     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.10.046     Document Type: Article

References (44)

1. http://www.who.int/whosis/whostat/2008/en/index.html.
2. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: final data for 2007. National vital statistics reports, vol. 58 no. 19. Hyattsville, MD: National Center for Health Statistics; 2010.
3. Scarborough P, Wickramasinghe K, Bhatnagar P, Rayner M. Trends in coronary heart disease 1961-2011. London: British Heart Foundation 2011.
4. RosamondW, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report fromtheAmerican Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117(4):e25-146.
5. Scarborough P, Bhatnagar P, Wickramasinghe K, Smolina K, Mitchell C, Rayner M. Coronary heart disease statistics. British Heart Foundation; 2010.
6. Allender S, Scarborough P, Peto V, et al. European cardiovascular disease statistics 2008. Brussels: European Heart Network; 2008.
7. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 1988;41:155-78.
8. Ragland KE, Selvin S, Merrill DW. The onset of decline in ischemic heart disease mortality in the United States. Am J Epidemiol 1988;127:516-31.
9. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999;353(9164):1547-57.
10. Rodríguez T, Malvezzi M, Chatenoud L, et al. Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000. Heart 2006;92(4):453-60.
11. Levi F, Chatenoud L, Bertuccio P, Lucchini F, Negri E, La Vecchia C. Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil 2009;16(3):333-50.
12. Roger VL. Epidemiology of myocardial infarction. Med Clin North Am 2007;91(4): 537-52.
13. World Health Organisation statistical Information System. WHO mortality database. http://www.who.int/healthinfo/statistics/mortality.
14. http://www.who.int/evidence/bod.
15. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray C. Global burden of disease and risk factors. Chapter 3The burden of disease and mortality by condition: data, methods, and results for 2001; 2001.
16. World Health Organisation. International statistical classification of disease and related health problems. 10th revision. World Health Organisation 1992.
17. http://esa.un.org/unpd/wpp/Excel-Data/population.htm.
18. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray C, Lozano R, Inoue M. Age standardisation of rates: a new WHO standard. GPE discussion paper series: no.31EIP/GPE/EBD. World Health Organization; 2001.
19. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002;88(2):119-24.
20. Goldman L. The decline in coronary heart disease: determining the paternity of success. Am J Med 2004;117:274-6.
21. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
22. EzzatiM, Hoorn SV, Rodgers A, et al. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003;362(9380):271-80.
23. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary event rates across the WHO MONICA project populations. Lancet 2000;355:675-87.
24. WHO Monica project. Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. Int J Epidemiol 1994;23:505-16.
25. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
26. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
27. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA project populations. Lancet 2000;355:688-700.
28. Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011;378(9798):1231-43.
29. Tunstall-Pedoe H for the WHO MONICA Project. MONICA monograph and multimedia sourcebook: world's largest study of heart disease, stroke, risk factors, and population trends 1979-2002. WHO 2003 [http://whqlibdoc.who.int/ publications/2003/9241562234].
30. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7.
31. Smolina K, Wright FL, RaynerM, Goldacre MJ. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 2012;344:d8059.
32. Roberts B, Gilmore A, Stickley A, et al. Changes in smoking prevalence in 8 countries of the former Soviet Union between 2001 and 2010. Am J Public Health 2012;102(7):1320-8.
33. Roberts B, Stickley A, Balabanova D, Haerpfer C, McKee M. The persistence of irregular treatment of hypertension in the former Soviet Union. J Epidemiol Community Health 2012;66(11):1079-82.
34. Kotseva K, Wood D, De Backer G, et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet Mar 14, 2009;373(9667):929-40.
35. Ramstedt M. Fluctuations in male ischaemic heart disease mortality in Russia 1959-1998: assessing the importance of alcohol. Drug Alcohol Rev 2009;28(4): 390-5.
36. Stuckler D, McKee M, Ebrahim S, Basu S. Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med 2012;9(6):e1001235.
37. http://www.who.int/bulletin/volumes/88/4/09-065847/en/index.html.
38. http://unstats.un.org/unsd/vitalstatkb/KnowledgebaseArticle50391.aspx.
39. http://unstats.un.org/unsd/vitalstatkb/Attachment476.aspx.
40. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007;370(9603):1929-38.
41. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet 2011;377(9775):1438-47.
42. Lim SS, Gaziano TA, Gakidou E, et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet 2007;370(9604):2054-62.
43. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007;370(9604):2044-53.
44. Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save? Lancet 2005;366(9496):1578-82.